Diethylcarbamazine
Contents
Description
Diethylcarbamazine is an anthelmintic drug that acts against filarial parasites by altering the surface properties of microfilariae, making them more susceptible to host immune responses. It is particularly effective against Dirofilaria species and other filarial infections. The drug has been used for decades in the treatment of lymphatic filariasis and related parasitic conditions.
Indications & Therapeutic Use
Lymphatic filariasis, tropical pulmonary eosinophilia, loiasis, dirofilariasis
Linked Diseases:
Global Availability (7 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Diethylcarbamazine — GNH India
3 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Browse all Diethylcarbamazine products on GNH IndiaProducts and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
| Generic Name | diethylcarbamazine |
| Brands | 1 brand available |
| Active Ingredient | diethylcarbamazine citrate |
| Drug Class | Lymphatic filariasis |
| Manufacturer | Various generic manufacturers |
| Dosage Forms | Oral tablet 50mg, 100mg |
| Medical Code | P02CB02 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 7 days |
| Reg. Status | FDA Approved (limited availability) |
| Countries | 7 countries |